COSMO Pharmaceuticals N.V.

COPN

Equity

ISIN NL0011832936 / Valor 32590356

SIX Swiss Exchange (2025-11-21)

CHF 67.10-0.45%

COSMO Pharmaceuticals N.V.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of gastrointestinal diseases. The company has successfully brought to market six approved drugs and two medical devices, addressing unmet medical needs in this therapeutic area. COSMO Pharmaceuticals is involved in the entire product lifecycle, from identifying medical needs and managing product development to obtaining regulatory approvals. The company licenses its approved products to partners with strong marketing and sales capabilities, ensuring effective market penetration. Additionally, COSMO offers a range of services related to pharmaceutical production, including the assessment of manufacturing processes, technology transfer, evaluation of product stability, market testing and release, and the preparation of necessary documentation for product registration.

Summarized from source with an LLMView SourceSector: Healthcare

Financial Performance

The consolidated and audited financial results for 2024 highlight Cosmo Pharmaceuticals' robust financial health and effective management throughout the fiscal year.

Revenue Growth

The company achieved exceptional revenue growth in 2024, reflecting successful market strategies and increased demand for its innovative healthcare products.

Dividend Proposal

The Board of Directors proposed a dividend distribution of €2.05 per share for 2024, up from €2.00 per share in the previous year, demonstrating a commitment to shareholder value.

Strategic Advancements

Significant strategic advancements were made in 2024, including collaborations with leading partners and the development of a clear roadmap for future corporate initiatives.

Summarized from source with an LLMView Source

Key figures

8.40%1Y

11.1%3Y

-19.8%5Y

Performance

36.1%1Y

29.9%3Y

31.2%5Y

Volatility